The sessions emphasized aligning Swiss innovation with India’s manufacturing potential, R&D capacity, and skilled talent pool ...

Piyush Goyal has called on Swiss firms to scale up their investments in India, positioning the country as a strategic base for manufacturing, innovation, and global market access.

AR1001 is a novel, disease-modifying, once-daily oral phosphodiesterase-5 (PDE5) inhibitor currently being studied in a global Phase 3 clinical trial (POLARIS-AD) for the treatment of early-stage ...